Technology to connect conventional fuel filling stations to the gas supply system, enabling them to refuel hydrogen-powered vehicles of the future, is being developed in a project led by researchers of the Warwick Process Technology Group, part of Warwick University, England.

A colourful combination of red light, blue dye and a plant hormone can be used to kill cancer cells with a lethal flurry of chemicals, according to a study by Cancer Research UK scientists.

"Most farmers' knowledge level when it comes to GM crops is just too low for them to make informed decisions." So says Angus Macneil, Chair of the Association Grains Committee, NSW Farmers' Association. [ + ]

Melbourne has been chosen as the site for the world's first Diabetes Vaccine Development Centre, a joint initiative of the National Health and Medical Research Council and the Juvenile Diabetes Research Foundation International. [ + ]

A drug manufacturing contract signed between two Brisbane biotech companies shows how Queensland's maturing biotech sector is creating opportunities for cross-pollination between its different layers. [ + ]

If Labor is re-elected to office in NSW on March 22 it will create a new State Minister for Science and Medical Research, and would also set up a new cancer institute, Premier Bob Carr has announced. [ + ]

Melbourne-based Genetic Technologies (GTG) has inked its biggest deal yet, with Swedish DNA company Pyrosequencing. [ + ]

US anti-cancer therapeutics company ImClone Systems has signed an agreement with UK antibody engineering company Domantis, to use Domantis' proprietary domain-antibody technology to develop new therapeutics. [ + ]

There's no easy way of popping a gene into human cells to repair or replace a defective gene -- at least, not yet. But Dr Andy Choo's research team at the Murdoch Children's Research Institute in Melbourne is developing such a technology: a sort of plug-and-play gene 'cassette' employing a tiny, but fully functional human artificial chromosome. [ + ]

Australian developers of a genetically-engineered vaccine against whooping cough are taking some of the wraps off their work in a bid to attract funding for human clinical trials. [ + ]

Government opposition to genetically modified food crops is hardening at the State level, even as the potential approval for such crops draws nearer at the Federal level. [ + ]

Institutional shareholders in Polartechnics have tipped another $AUD3.63 million into the medical devices company, buoyed by the belief it is on the threshold of commercial viability. [ + ]

Half year results for drug developer Progen Industries reveal revenues from its contract drug manufacturing and life sciences sales and distribution arms continue to rise, helping offset development costs of its anti-cancer drug candidates. [ + ]

Researchers at Monash University have begun sifting through the database from Australia's first bacterial genome project, looking for targets for a vaccine against an unusual microbe that can kill, or leave survivors chronically depressed. [ + ]

Queensland biotechnology company Benitec says CSIRO has "no claim" to its patented technology for gene silencing by RNA interference (RNAi). [ + ]